e-learning
resources
Munich 2006
Tuesday 05.09.2006
Biological features, lung function and treatment of lung cancer
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The role of serum copper and zinc levels and copper/zinc ratio in lung cancer
S. S. Hacievliyagil, H. Gunen, L. C. Mutlu, G. Gülbas, O. Yetkin, H. Atmaca (Malatya, Turkey)
Source:
Annual Congress 2006 - Biological features, lung function and treatment of lung cancer
Session:
Biological features, lung function and treatment of lung cancer
Session type:
Electronic Poster Discussion
Number:
4420
Disease area:
Thoracic oncology
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. S. Hacievliyagil, H. Gunen, L. C. Mutlu, G. Gülbas, O. Yetkin, H. Atmaca (Malatya, Turkey). The role of serum copper and zinc levels and copper/zinc ratio in lung cancer. Eur Respir J 2006; 28: Suppl. 50, 4420
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
The contribution of serum ferritin, iron, iron binding capacity and bronchoalveolar lavage ferritin levels in differential diagnosis of lung cancer from benign pulmonary diseases
Source: Annual Congress 2007 - Biology, diagnosis and rare tumours in thoracic malignancies
Year: 2007
The role of iron and transferrin serum levels in lung cancer patients - a single institution experience
Source: Eur Respir J 2005; 26: Suppl. 49, 330s
Year: 2005
Evaluation of serum levels of Sirtuin-1 in lung cancer patients
Source: Virtual Congress 2020 – Prognostic and predictive factors: treatment of lung cancer
Year: 2020
Elevated serum levels of oxidative stress biomarkers in patients with lung cancer
Source: Annual Congress 2010 - Biomarkers for lung cancer
Year: 2010
Analysis of zinc,copper and copper /zinc values in serum and hair of new and chronic cases of pulmonary parenchymal tuberculosis
Source: Eur Respir J 2003; 22: Suppl. 45, 160s
Year: 2003
Could exhaled ferritin and SOD be used as markers for lung cancer and prognosis prediction purposes?
Source: Annual Congress 2011 - Role of the biomarkers in airway diseases
Year: 2011
Low levels of heme oxygenase-1 in induced sputum of lung cancer patients as a marker of defective cytoprotection
Source: Annual Congress 2012 - New biomarkers for lung cancer
Year: 2012
The importance of erythrocyte superoxide dismutase activity and serum vitamin C concentration assay in children with asthma
Source: Annual Congress 2006 - Aspects of childhood asthma
Year: 2006
Clinical significance of serum osteopontin levels in lung cancer
Source: Annual Congress 2012 - New biomarkers for lung cancer
Year: 2012
The study on the association of serum C-reactive protein level with the risk of lung cancer
Source: Annual Congress 2009 - Various diagnostic aspects in lung cancer and rare lung tumours
Year: 2009
Disturbance of systemic antioxidant profile in nonsmall cell lung carcinoma
Source: Eur Respir J 2007; 29: 273-278
Year: 2007
Increased levels of plasmatic dopamine in human small cell lung cancer
Source: Annual Congress 2012 - New biomarkers for lung cancer
Year: 2012
Evaluation of oxidant-antioxidant status in different stages of COPD: determination of serum paraoxonase1 and malonyldialdehyde levels
Source: Annual Congress 2009 - COPD: from biomarker profiling to clinical assessment
Year: 2009
Plasma total antioxidant status and erythrocyte antioxidant enzyme activities in lung cancer in Turkey
Source: Eur Respir J 2001; 18: Suppl. 33, 233s
Year: 2001
Usefulness of serum procalcitonin in lung cancer patients with elevated serum C-reactive protein level
Source: Annual Congress 2011 - Instructive clinical aspects of lung cancer
Year: 2011
Serum haem oxygenase-1 as marker of lung function in patients with chronic silicosis
Source: Annual Congress 2009 - Old and new topics in environmental and occupational lung disease
Year: 2009
IGF-I and IGFBP-3 concentrations in the blood serum and lung cancer risk
Source: Annual Congress 2007 - Biology of thoracic malignancies
Year: 2007
CEA levels in the serum and induced sputum of lung cancer patients
Source: Eur Respir J 2005; 26: Suppl. 49, 324s
Year: 2005
Experimental emphysema: effect of tocopherol on serum lipid profile and iron content in lung tissue
Source: Eur Respir J 2005; 26: Suppl. 49, 93s
Year: 2005
Serum hepcidin and iron are associated with non-small cell lung cancer stage
Source: International Congress 2016 – Prognostic variables in lung cancer I
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept